RIPK1 inhibits ZBP1-driven necroptosis during development.
Kim Newton1, Katherine E Wickliffe1, Allie Maltzman1
1Department of Physiological Chemistry, Genentech, 1 DNA Way, South San Francisco, California 94080, USA.
Nature
|November 8, 2016
Summary
Receptor-interacting protein kinase 1 (RIPK1) normally prevents Z-DNA binding protein 1 (ZBP1) from activating RIPK3-dependent necroptosis. Loss of RIPK1
Area of Science:
- Cellular biology
- Immunology
- Molecular mechanisms of cell death
Background:
- Receptor-interacting protein kinase 1 (RIPK1) is crucial for cell survival, as RIPK1 deficiency leads to perinatal lethality due to aberrant apoptosis and necroptosis.
- While catalytically inactive RIPK1 mutants allow survival, suggesting a scaffold function, the precise role of RIPK1 in regulating cell death pathways remains incompletely understood.
- The RIP homotypic interaction motif (RHIM) is a key domain in RIPK1 involved in protein-protein interactions within cell death signaling.
Purpose of the Study:
- To investigate the role of the RIP homotypic interaction motif (RHIM) of Receptor-interacting protein kinase 1 (RIPK1) in preventing programmed cell death during development.
- To elucidate the interaction between RIPK1, Z-DNA binding protein 1 (ZBP1), and RIPK3 in the context of necroptosis regulation.
- To determine if ZBP1-mediated RIPK3 activation contributes to the lethality observed in mice with impaired RIPK1 function.
Main Methods:
- Generation and analysis of Ripk1RHIM/RHIM mice with mutated RIPK1 RHIM residues.
- Assessment of necroptosis markers (RIPK3 autophosphorylation) and lethality in genetically modified mouse models (e.g., Ripk3 knockout, MLKL knockout).
- Co-immunoprecipitation assays to study protein-protein interactions between ZBP1 and RIPK3 in various genetic backgrounds.
Main Results:
- Mice expressing RIPK1 with a mutated RHIM (Ripk1RHIM/RHIM) exhibited perinatal lethality and RIPK3 autophosphorylation, indicating necroptosis.
- Blocking necroptosis through genetic deficiency of RIPK3 or MLKL, or by using catalytically inactive RIPK3, rescued lethality in Ripk1RHIM/RHIM mice.
- Loss of Z-DNA binding protein 1 (ZBP1) also prevented lethality in Ripk1RHIM/RHIM mice, and ZBP1 interacted with RIPK3 in the absence of functional RIPK1 and MLKL.
Conclusions:
- The RHIM domain of RIPK1 acts as a critical brake, preventing ZBP1 from inappropriately engaging RIPK3 and initiating necroptosis during development.
- ZBP1-RIPK3-MLKL-dependent necroptosis is a key pathway that must be suppressed by RIPK1 for normal embryonic and perinatal survival.
- These findings reveal a novel inhibitory role for the RIPK1 RHIM in safeguarding development by controlling ZBP1-mediated necroptotic signaling.
Related Concept Videos
01:16Necrosis
7.1K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
7.1K
01:31The Intrinsic Apoptotic Pathway
9.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
01:17The Extrinsic Apoptotic Pathway
9.2K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.2K
01:31Regulation of the Unfolded Protein Response
3.2K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K
01:30Overview of Cell Death
10.8K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.8K